Although previous animal studies have shown that peripheral levodopa is correlated with insulin secretion in pancreatic beta cells, the mechanism by which the pancreas uses levodopa differently in humans with obesity and type 2 diabetes remains unknown. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.